Panel discussion on novel therapies and targets for lymphoma
John Gribben et al.
Establishing standardized guidelines on eosinophilia investigation and management in the UK
Increasing the effectiveness of ALL therapies
What impact have new minimal residual disease (MRD) assessment techniques had in myeloma?
Managing AML in elderly patients